Home

Glenmark Life Sciences Ltd PB Ratio

Image

Glenmark Life Sciences Ltd

NSE: GLS

PB

5.1

Last updated on: 22 Nov 24

Key Highlights

  • The latest PB Ratio of Glenmark Life Sciences Ltd is 5.1.
  • The PB ratio of the Glenmark Life Sciences Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
  • The P/B Ratio of Glenmark Life Sciences Ltd changed from 2.7 on March 2022 to 4.1 on March 2024 . This represents a CAGR of 14.94% over 3 years.

Historical P/B Ratio of Glenmark Life Sciences Ltd

No data available

Company Fundamentals for Glenmark Life Sciences Ltd

Market Cap

12,852 Cr

EPS

34.6

P/E Ratio (TTM)

30.4

P/B Ratio (TTM)

5.1

Day’s High

1108.15

Day’s Low

1024.7

DTE

0.0

ROE

16.7

52 Week High

1335.0

52 Week Low

620.05

ROCE

22.3

Market Price of Glenmark Life Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 20241048.9
21 Nov 20241081.15
19 Nov 20241084
18 Nov 20241082.05
14 Nov 20241080.35

SWOT Analysis Of Glenmark Life Sciences Ltd

Strength

2

che

Weakness

2

che

Opportunity

1

che

Threats

0

che

BlinkX Score for Glenmark Life Sciences Ltd

Asset Value vs Market Value of Glenmark Life Sciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/B Ratio

Company
leftPBright
Glenmark Life Sciences Ltd5.06
Sun Pharmaceuticals Industries Ltd98.7
Divis Laboratories Ltd525.7
Cipla Ltd364.9
Torrent Pharmaceuticals Ltd229.2

Historical Market Cap of Glenmark Life Sciences Ltd

Market Cap

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Glenmark Life Sciences Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

FAQs for PB Ratio of Glenmark Life Sciences Ltd

What is the PB ratio of Glenmark Life Sciences Ltd?

The current PB ratio of Glenmark Life Sciences Ltd is 5.06. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Glenmark Life Sciences Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Glenmark Life Sciences Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Glenmark Life Sciences Ltd calculated?

The PB ratio of Glenmark Life Sciences Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Glenmark Life Sciences Ltd?

A high PB ratio suggests that Glenmark Life Sciences Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Glenmark Life Sciences Ltd?

A low PB ratio of Glenmark Life Sciences Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Glenmark Life Sciences Ltd PB Ratio change over time?

Yes, the PB ratio of Glenmark Life Sciences Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*